Clinical trials
Phase 2 Ocular Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 5 |
| 2009 | 11 |
| 2010 | 7 |
| 2011 | 10 |
| 2012 | 7 |
| 2013 | 8 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 101 |
| Terminated | 4 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 21 |
| Aerie Pharmaceuticals | 13 |
| Mati Therapeutics Inc. | 11 |
| Allergan | 8 |
| Santen Inc. | 6 |
| Qlaris Bio, Inc. | 5 |
| ForSight Vision5, Inc. | 4 |
| Bausch & Lomb Incorporated | 3 |
| Glaukos Corporation | 3 |
| Amakem, NV | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ocular Hypertension | 113 |
| Glaucoma, Open-Angle | 86 |
| Glaucoma | 51 |
| Hypertension | 5 |
| Eye Diseases | 3 |
| Sturge-Weber Syndrome | 2 |
| Exfoliation Syndrome | 1 |
| Hydrophthalmos | 1 |
| Low Tension Glaucoma | 1 |
Trials
Showing 51 to 75 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.